Abstract
Mycobacterial infections (particularly, tuberculosis caused by Mycobacterium tuberculosis) represent a significant threat to public health, especially south of the Sahara. The problem has been compounded by poor patient compliance due to long periods of treatment, thus resulting in the development of multi-drug resistant (MDR) and extremely drugresistant (XDR) forms the of bacterium. It has, therefore, become imperative to seek new drugs from unexplored sources against these infections. Natural products, from ancient times, have often been used as drugs for the treatment of various ailments. They have also served as templates for the design and synthesis of new drugs. In sub-Saharan Africa particularly, ethnobotanical and ethnomedical knowledge of plants has been exploited to manage several different ailments, including tuberculosis. Thus research efforts have often been concentrated on plants as a source of treatment of diseases as well as drug leads. In this mini review, we report the biological activities of compounds derived from African medicinal plants with the potential for the treatment of anti-mycobacterial infections. Seventy nine (79) antimycobacterial compounds have been identified in sub-Sahara Africa covering the period from 1995 to 2013.
Keywords: Drug discovery, medicinal plants, mycobacterial infections, natural products, tuberculosis.
Anti-Infective Agents
Title:Potential Natural Antimycobacterial Metabolites from Some Sub-Saharan Medicinal Plants
Volume: 12 Issue: 2
Author(s): Joseph N. Yong and Fidele Ntie-Kang
Affiliation:
Keywords: Drug discovery, medicinal plants, mycobacterial infections, natural products, tuberculosis.
Abstract: Mycobacterial infections (particularly, tuberculosis caused by Mycobacterium tuberculosis) represent a significant threat to public health, especially south of the Sahara. The problem has been compounded by poor patient compliance due to long periods of treatment, thus resulting in the development of multi-drug resistant (MDR) and extremely drugresistant (XDR) forms the of bacterium. It has, therefore, become imperative to seek new drugs from unexplored sources against these infections. Natural products, from ancient times, have often been used as drugs for the treatment of various ailments. They have also served as templates for the design and synthesis of new drugs. In sub-Saharan Africa particularly, ethnobotanical and ethnomedical knowledge of plants has been exploited to manage several different ailments, including tuberculosis. Thus research efforts have often been concentrated on plants as a source of treatment of diseases as well as drug leads. In this mini review, we report the biological activities of compounds derived from African medicinal plants with the potential for the treatment of anti-mycobacterial infections. Seventy nine (79) antimycobacterial compounds have been identified in sub-Sahara Africa covering the period from 1995 to 2013.
Export Options
About this article
Cite this article as:
Yong N. Joseph and Ntie-Kang Fidele, Potential Natural Antimycobacterial Metabolites from Some Sub-Saharan Medicinal Plants, Anti-Infective Agents 2014; 12 (2) . https://dx.doi.org/10.2174/2211352512666140417002335
DOI https://dx.doi.org/10.2174/2211352512666140417002335 |
Print ISSN 2211-3525 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-3533 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Urokinase Receptor System, A Key Regulator at the Intersection between Inflammation, Immunity, and Coagulation
Current Pharmaceutical Design Lipids as Activators of Innate Immunity in Peptide Vaccine Delivery
Current Medicinal Chemistry Behcets Syndrome: Literature Review
Current Rheumatology Reviews Metabolism Evolution Based on Network Degrees of Orthologous Enzymes
Current Topics in Medicinal Chemistry A Comprehensive Review on the Biological and Pharmacological Activities of Rhodanine Based Compounds for Research and Development of Drugs
Mini-Reviews in Medicinal Chemistry Biographical Sketches of Authors
Current Topics in Medicinal Chemistry Synthesis and Biological Evaluation of 2-thiazolylimino-5-arylidene-4- thiazolidinone Derivatives as Potent Antimycobacterial Agents
Anti-Infective Agents Understanding the Molecular Mechanisms of Rifaximin in the Treatment of Gastrointestinal Disorders – A Focus on the Modulation of Host Tissue Function
Mini-Reviews in Medicinal Chemistry Mechanisms Involved in the Genesis of Diabetic Nephropathy
Current Diabetes Reviews General Principles for the Treatment of Non-Infectious Uveitis
Inflammation & Allergy - Drug Targets (Discontinued) Pyrimidine Salvage Pathway in Mycobacterium tuberculosis
Current Medicinal Chemistry Targeting Intracellular Targets
Current Drug Delivery Pharmacogenomics of Arylamine N-acetyltransferase
Current Pharmacogenomics Acetate Kinase (AcK) is Essential for Microbial Growth and Betel-derived Compounds Potentially Target AcK, PhoP and MDR Proteins in M. tuberculosis, V. cholerae and Pathogenic E. coli: An in silico and in vitro Study
Current Topics in Medicinal Chemistry Advances of Phenoxazines: Synthesis, Reactivity and Their Medicinal Applications
Current Medicinal Chemistry Microbial Drug Efflux Proteins of the Major Facilitator Superfamily
Current Drug Targets Evaluation of Dendrimer Safety and Efficacy through Cell Line Studies
Current Drug Targets Current Discovery Progress of Some Emerging Anti-infective Chalcones: Highlights from 2016 to 2017
Current Drug Discovery Technologies Non-Invasive Immunization on the Skin Using DNA Vaccine
Current Drug Delivery A Comprehensive Review on Phytochemistry and Pharmacological Effects of Stinging Nettle (Urtica dioica)
Current Traditional Medicine